ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
阅读更多
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty).
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.
History
Resmed was established in June 1989 by Peter Farrell in Australia. The company opened an office in San Diego in 1992, and made that its headquarters two years later when it incorporated in the US.
Leadership
On March 1, 2013, Peter's son Mick Farrell became the company's new CEO. Peter transitioned to a non-executive role at the end of the year.
In November 2023, there were many changes to the executive team at Resmed. Rob Douglas stepped down as the chief operating officer and president after announcing he would retire in January 2024. In the same month, it was announced that Justin Leong would serve as the chief product officer. Leong will also take over the digital health technology team. Katrin Pucknat will serve as the new chief marketing officer and Mike Fliss will serve as the new chief revenue officer.
False claims settlement
In January 2020, Resmed Inc. agreed to pay more than $37.5 million to resolve alleged kickbacks paid to durable medical equipment suppliers, sleep labs, and other healthcare providers in violation of the Anti-Kickback Statute.
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
内部人士在
内部人士交易
价格变动与当前报价相比，按自申报以来的公司行为进行拆股调整 — 未进行基准比较，未年化，未按市值加权
无公开市场交易记录；显示所有文件。
| 日期 | 股票代码 | 代码 | 股份 | 价格 | 价值 | 之后持有 | Δ 持股 | A/D | 与现在相比 |
|---|---|---|---|---|---|---|---|---|---|
| 2021年11月18日 | RMD | A | 956 | — | — | 13823 直接 | +7.43% | 获得 | （截至2026-08-21的价格） |
买入 = 公开市场购买 · 卖出 = 出售 · 授予 = 授予/奖励 · M = 期权行权 · 行权 = 赠与 · 弃权 = 税款扣缴
内幕交易并非投资建议；出售行为通常是出于流动性或税务原因。